These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 32325250)

  • 1. Disruption of the aldehyde dehydrogenase 2 gene increases the bone anabolic response to intermittent PTH treatment in an ovariectomized mouse model.
    Kosugi K; Tajima T; Menuki K; Okuma KF; Tokuda K; Fukuda H; Okada Y; Tsukamoto M; Yamanaka Y; Zenke Y; Sakai A
    Bone; 2020 Jul; 136():115370. PubMed ID: 32325250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cortical bone loss due to skeletal unloading in aldehyde dehydrogenase 2 gene knockout mice is associated with decreased PTH receptor expression in osteocytes.
    Tajima T; Menuki K; Okuma KF; Tsukamoto M; Fukuda H; Okada Y; Kosugi K; Yamanaka Y; Uchida S; Sakai A
    Bone; 2018 May; 110():254-266. PubMed ID: 29482068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basal bone phenotype and increased anabolic responses to intermittent parathyroid hormone in healthy male COX-2 knockout mice.
    Xu M; Choudhary S; Voznesensky O; Gao Q; Adams D; Diaz-Doran V; Wu Q; Goltzman D; Raisz LG; Pilbeam CC
    Bone; 2010 Aug; 47(2):341-52. PubMed ID: 20471507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intermittent Ibandronate Maintains Bone Mass, Bone Structure, and Biomechanical Strength of Trabecular and Cortical Bone After Discontinuation of Parathyroid Hormone Treatment in Ovariectomized Rats.
    Takeda S; Sakai S; Tanaka K; Tomizawa H; Serizawa K; Yogo K; Urayama K; Hashimoto J; Endo K; Matsumoto Y
    Calcif Tissue Int; 2017 Jul; 101(1):65-74. PubMed ID: 28246925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disruption of aldehyde dehydrogenase 2 gene results in altered cortical bone structure and increased cortical bone mineral density in the femoral diaphysis of mice.
    Tsuchiya T; Sakai A; Menuki K; Mori T; Takeuchi Y; Kanoh S; Utsunomiya H; Murai T; Isse T; Kawamoto T; Nakamura T
    Bone; 2013 Apr; 53(2):358-68. PubMed ID: 23313283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone response to intermittent parathyroid hormone is altered in mice null for {beta}-Arrestin2.
    Ferrari SL; Pierroz DD; Glatt V; Goddard DS; Bianchi EN; Lin FT; Manen D; Bouxsein ML
    Endocrinology; 2005 Apr; 146(4):1854-62. PubMed ID: 15705780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of the bone metabolic response to dried plum supplementation and PTH treatment in adult, osteopenic ovariectomized rat.
    Smith BJ; Bu SY; Wang Y; Rendina E; Lim YF; Marlow D; Clarke SL; Cullen DM; Lucas EA
    Bone; 2014 Jan; 58():151-9. PubMed ID: 24125756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined treatment with a beta-blocker and intermittent PTH improves bone mass and microarchitecture in ovariectomized mice.
    Pierroz DD; Bouxsein ML; Rizzoli R; Ferrari SL
    Bone; 2006 Aug; 39(2):260-7. PubMed ID: 16531131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pregnancy-associated plasma protein-A modulates the anabolic effects of parathyroid hormone in mouse bone.
    Clifton KB; Conover CA
    Bone; 2015 Dec; 81():413-416. PubMed ID: 26297833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclooxygenase-2 suppresses the anabolic response to PTH infusion in mice.
    Choudhary S; Canalis E; Estus T; Adams D; Pilbeam C
    PLoS One; 2015; 10(3):e0120164. PubMed ID: 25781979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CREM deficiency in mice alters the response of bone to intermittent parathyroid hormone treatment.
    Liu F; Lee SK; Adams DJ; Gronowicz GA; Kream BE
    Bone; 2007 Apr; 40(4):1135-43. PubMed ID: 17275432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. β-Arrestin 2 knockout prevents bone loss in response to continuous parathyroid hormone stimulation in male and female mice.
    Li Feng G; Grynpas MD; Mitchell J
    Connect Tissue Res; 2023 Jul; 64(4):350-361. PubMed ID: 37046359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporal expression of the anabolic action of PTH in cancellous bone of ovariectomized rats.
    Meng XW; Liang XG; Birchman R; Wu DD; Dempster DW; Lindsay R; Shen V
    J Bone Miner Res; 1996 Apr; 11(4):421-9. PubMed ID: 8992872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parathyroid hormone (PTH)/PTH-related peptide type 1 receptor (PPR) signaling in osteocytes regulates anabolic and catabolic skeletal responses to PTH.
    Saini V; Marengi DA; Barry KJ; Fulzele KS; Heiden E; Liu X; Dedic C; Maeda A; Lotinun S; Baron R; Pajevic PD
    J Biol Chem; 2013 Jul; 288(28):20122-34. PubMed ID: 23729679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential transcriptional effects of PTH and estrogen during anabolic bone formation.
    von Stechow D; Zurakowski D; Pettit AR; Müller R; Gronowicz G; Chorev M; Otu H; Libermann T; Alexander JM
    J Cell Biochem; 2004 Oct; 93(3):476-90. PubMed ID: 15372627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nmp4/CIZ suppresses the response of bone to anabolic parathyroid hormone by regulating both osteoblasts and osteoclasts.
    Childress P; Philip BK; Robling AG; Bruzzaniti A; Kacena MA; Bivi N; Plotkin LI; Heller A; Bidwell JP
    Calcif Tissue Int; 2011 Jul; 89(1):74-89. PubMed ID: 21607813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disruption of the Aldehyde Dehydrogenase 2 Gene Results in No Increase in Trabecular Bone Mass Due to Skeletal Loading in Association with Impaired Cell Cycle Regulation Through p21 Expression in the Bone Marrow Cells of Mice.
    Okuma KF; Menuki K; Tsukamoto M; Tajima T; Fukuda H; Okada Y; Mori T; Tsuchiya T; Kawamoto T; Yoshida Y; Uchida S; Sakai A
    Calcif Tissue Int; 2017 Sep; 101(3):328-340. PubMed ID: 28474171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amphiregulin lacks an essential role for the bone anabolic action of parathyroid hormone.
    Jay FF; Vaidya M; Porada SM; Andrukhova O; Schneider MR; Erben RG
    Mol Cell Endocrinol; 2015 Dec; 417():158-65. PubMed ID: 26427650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The anabolic action of intermittent PTH in combination with cathepsin K inhibitor or alendronate differs depending on the remodeling status in bone in ovariectomized mice.
    Yamane H; Sakai A; Mori T; Tanaka S; Moridera K; Nakamura T
    Bone; 2009 Jun; 44(6):1055-62. PubMed ID: 19303837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disruption of LRP6 in osteoblasts blunts the bone anabolic activity of PTH.
    Li C; Xing Q; Yu B; Xie H; Wang W; Shi C; Crane JL; Cao X; Wan M
    J Bone Miner Res; 2013 Oct; 28(10):2094-108. PubMed ID: 23609180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.